Title : CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation.

Pub. Date : 2003 Dec

PMID : 14713576






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation. Tretinoin cellular retinoic acid binding protein 1 Homo sapiens
2 PURPOSE: To examine the role cytoplasmic retinoic acid binding protein type 1 (CRABP I) and retinoic acid receptor beta 2 (RAR-beta 2) in mediating radiosensitization of human tumour cells in vitro by retinoic acid. Tretinoin cellular retinoic acid binding protein 1 Homo sapiens
3 The retinoic acid-sensitive cell line HTB35 was transfected for inducible CRABP I overexpression to test the role of this protein in modulating the sensitivity to retinoic acid and radiation as well as in regulating RAR-beta 2 and cyclin D1 expression. Tretinoin cellular retinoic acid binding protein 1 Homo sapiens
4 RESULTS: The basal CRABP I level clearly correlated with the clonogenic survival of tumour cells and normal fibroblasts after treatment with retinoic acid and ionizing irradiation (IR). Tretinoin cellular retinoic acid binding protein 1 Homo sapiens
5 Cells expressing high basal CRABP I were more resistant to combined retinoic acid radiation treatment than cells with low basal expression. Tretinoin cellular retinoic acid binding protein 1 Homo sapiens
6 Overexpression of CRABP I in retinoic acid-sensitive HTB35 cells induced a retinoic acid-insensitive phenotype resistant to combined treatment with retinoic acid and radiation. Tretinoin cellular retinoic acid binding protein 1 Homo sapiens
7 CRABP I overexpression resulted in stimulated cyclin D1 expression indicating the dependency of this cell cycle control protein on retinoic acid metabolism. Tretinoin cellular retinoic acid binding protein 1 Homo sapiens
8 CONCLUSION: CRABP I plays an important role not only in mediating the retinoid effects, but also in modulating the radiation sensitivity of tumour cells after combined retinoic acid radiation treatment. Tretinoin cellular retinoic acid binding protein 1 Homo sapiens